LOGIN
AAOS 2016: Liposomal bupivacaine for postoperative analgesia after shoulder arthroplasty
March 2016
AAOS 2016: Liposomal bupivacaine for postoperative analgesia after shoulder arthroplasty
Study Type:Randomized Trial
OE Level Evidence:N/A
Journal Level of Evidence:N/A
Randomized Controlled Trial of Interscalene Block vs. Injectable Liposomal Bupivacaine in Shoulder Arthroplasty
Did you know you're eligible to earn 0.5 CME credits for reading this report? Click Here
CONFERENCE ACE REPORTS
This ACE Report is a summary of a conference presentation or abstract. The information provided has limited the ability to provide an accurate assessment of the risk of bias or the overall quality. Please interpret the results with caution as trials may be in progress and select results may have been presented.
Synopsis
106 patients undergoing either conventional or reverse total shoulder arthroplasty due to osteoarthritis or cuff tear arthropathy were randomized to postoperative analgesia via liposomal bupivacaine injection or interscalene brachial plexus blockade (ISBPB). The results from this study indicated that postoperative morphine equivalent units were similar between treatments; however, liposomal bupiva...
To view the full content, login to your account,
or start your 30-day FREE Trial today.
FREE TRIAL
LOGIN
Forgot Password?
Explore some of our unlocked ACE Reports below!
Learn about our AI Driven
High Impact Search Feature
The OE High Impact metric uses AI to determine the impact a study will have by considering the content of the article itself. Built using the latest advances of natural language processing techniques. OE High Impact predicts an article’s future number of citations than impact factor alone.
Continue
Join the Conversation
Please Login or Join to leave comments.